Related Experiment Video
Updated: Jul 17, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Advances in the prevention and treatment of cardiovascular disease
Myron L Weisfeldt1, Susan J Zieman
1Department of the Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA. mlw5@jhmi.edu
Insights
Cardiovascular disease mortality in the U.S. has dropped 50% over 35 years due to improved prevention, diagnosis, and treatment. Future efforts focus on lifestyle, screening, and new drugs to further reduce heart disease and stroke.
Area of Science:
- Cardiology
- Public Health
- Medical Innovation
Background:
- Cardiovascular disease remains a leading cause of death globally.
- Significant advancements in medical science have been made over the past 35 years.
- U.S. age-adjusted mortality from cardiovascular disease has seen a 50% decline.
Purpose of the Study:
- To review the key factors contributing to the reduction in cardiovascular disease mortality.
- To highlight the role of pharmaceutical agents and device-based therapies.
- To discuss future directions for cardiovascular disease prevention and treatment.
Main Methods:
- Review of epidemiological data on cardiovascular disease mortality trends.
- Analysis of the impact of pharmaceutical interventions on atherosclerosis.
- Evaluation of the contribution of novel device-based therapies and imaging techniques.
Main Results:
- A 50% decrease in U.S. age-adjusted cardiovascular disease mortality over 35 years.
- Pharmaceutical agents are crucial in preventing atherosclerosis and its major consequences (heart attack, stroke, heart failure).
- Device-based therapies and advanced imaging have significantly reduced cardiac morbidity and mortality.
Conclusions:
- Advances in prevention, diagnosis, and treatment have dramatically improved cardiovascular outcomes.
- Continued progress relies on lifestyle changes, early risk-factor screening, and development of more effective drugs.
- There is optimism for further substantial reductions in cardiovascular disease burden in the future.
Abstract:
Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions. Pharmaceutical agents play a major role in prevention of atherosclerosis and its consequences: heart attack, stroke, and heart failure. Additionally, novel device-based therapies contribute to the decline in cardiac morbidity and mortality. Whereas innovative strategies based on accurate imaging of the heart and blood vessels are implemented widely now, hope exists that lifestyle changes, early risk-factor screening, and more efficacious drugs will strikingly reduce cardiovascular disease in the future.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
